Objective. To present any congenital anomalies with respect to tumor necrosis factor (TNF)
antagonists reported to the US Food and Drug Administration (FDA) to determine if there are …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective
for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with …

Objective Chlamydia trachomatis and Chlamydophila (Chlamydia) pneumoniae are known
triggers of reactive arthritis (ReA) and exist in a persistent metabolically active infection state …

The purpose of this study is to review the background, safety, and potential complications of
silicone breast implants. Relevant studies were identified using a MEDLINE search of the …

Purpose: The prevalence and characteristics of the rheumatic and extra-rheumatic manifestations
of human immunodeficiency virus (HIV) infection were determined in a prospective …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective
in the treatment of reactive arthritis (ReA) that has been unresponsive to nonsteroidal …

Objective. The aim of this study was to analyse the prevalence of occult destructive arthropathy
in subjects with gout and normal plain radiographs by utilizing MRI and ultrasound (US). …

Inflammatory conditions that may require the use of a tumor necrosis factor-a (TNF-a) antagonist
often involve women of child-bearing age. TNF-a antagonists are presumed to be safe …

Objective The majority of patients with Chlamydia‐induced reactive arthritis do not present
with the classic triad of arthritis, conjunctivitis/iritis, and urethritis. Moreover, acute chlamydial …